⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27749989 | 0.89 | — | — | |
| SCHEMBL27634310 | 0.69 | — | — | |
| SCHEMBL1107779 | 0.69 | — | — | |
| SCHEMBL27705139 | 0.67 | — | — | |
| SCHEMBL27326215 | 0.67 | — | — | |
| SCHEMBL27958459 | 0.67 | — | — | |
| SCHEMBL27742762 | 0.67 | — | — | |
| SCHEMBL22698345 | 0.66 | — | — | |
| SCHEMBL28244387 | 0.65 | — | — | |
| SCHEMBL29224578 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130084312-A1 | NANOPARTICLES FOR DELIVERY OF BIOACTIVE AGENTS | ROSE PHARMACEUTICALS, LLC (US) | 2013-04-04 | — | — | US | disclosed |
| WO-2012174020-A2 | NANOPARTICLES FOR DELIVERY OF BIOACTIVE AGENTS | ROSE PHARMACEUTICALS, LLC (US) | 2012-12-20 | — | — | WO | disclosed |
| EP-1018884-B1 | METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS | LAYTON BIOSCIENCE INC (US) | 2005-10-26 | — | — | EP | disclosed |
| EP-1018884-A4 | METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS | LAYTON BIOSCIENCE INC (US) | 2002-06-12 | — | — | EP | disclosed |
| US-6162428-A | hNT-neuron human neuronal cells to replace ganglion cells | LAYTON BIOSCIENCE, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| EP-1018884-A1 | METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS | Layton Bioscience, Inc. (US) | 2000-07-19 | — | — | EP | disclosed |
| WO-1998034485-A9 | METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS | — | 1999-01-07 | — | — | WO | disclosed |
| WO-1998034485-A1 | METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS | LAYTON BIOSCIENCE, INC. (US) | 1998-08-13 | — | — | WO | disclosed |